Article

Myopic keratophakia considered alternative for correction of high myopia

Correction of high myopia with a phakic IOL or by clear lens exchange does pose some risks for patients because these methods are intraocular procedures. To avoid the associated risks of IOL surgery - such as infection, cataract formation in the case of phakic lenses, possible endothelial damage, pupil ovalization, or zonular problem - surgeons might want to consider myopic keratophakia and excimer laser ablation instead, explained Luis A. Ruiz, MD.

Correction of high myopia with a phakic IOL or by clear lens exchange does pose some risks for patients because these methods are intraocular procedures. To avoid the associated risks of IOL surgery - such as infection, cataract formation in the case of phakic lenses, possible endothelial damage, pupil ovalization, or zonular problem - surgeons might want to consider myopic keratophakia and excimer laser ablation instead, explained Luis A. Ruiz, MD.

Dr. Ruiz, a cataract and refractive surgeon from Bogota, Colombia, showed a video demonstrating this technique in a patient with high myopia, during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting.

A flap is created with a microkeratome and lifted, similar to the start of a LASIK procedure. A donor tissue lenticule measuring 7 mm in diameter is placed on the stroma and the surgeon continues with the excimer laser ablation. The flap is replaced and the edges dried to avoid striae.

He reported the results of 21 eyes of 13 patients with a mean age of 33 years (range, 17 to 42) who underwent this procedure. The mean preoperative sphere was -13.55 D (range, -0.75 to -23 D), and there were three cases of low myopia but they had high astigmatism.

The mean preoperative spherical equivalent (SE) was -15.36 D (range, -4.26 to -0.5 D). The average follow-up was 4.1 years (range, 1 to 7 years).

The mean postoperative SE was -0.63 D and the mean postoperative cylinder was -0.81 D, he reported.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.